155 related articles for article (PubMed ID: 34731761)
1. Construction and activity evaluation of novel benzodioxane derivatives as dual-target antifungal inhibitors.
An Y; Liu W; Xie H; Fan H; Han J; Sun B
Eur J Med Chem; 2022 Jan; 227():113950. PubMed ID: 34731761
[TBL] [Abstract][Full Text] [Related]
2. Construction and activity evaluation of novel dual-target (SE/CYP51) anti-fungal agents containing amide naphthyl structure.
Liu W; Sun Z; An Y; Liu Y; Fan H; Han J; Sun B
Eur J Med Chem; 2022 Jan; 228():113972. PubMed ID: 34772530
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis and bioactivity evaluation of novel arylalkene-amide derivatives as dual-target antifungal inhibitors.
Sun B; Dong Y; An Y; Liu M; Han J; Zhao L; Liu X
Eur J Med Chem; 2020 Nov; 205():112645. PubMed ID: 32791399
[TBL] [Abstract][Full Text] [Related]
4. Novel naphthylamide derivatives as dual-target antifungal inhibitors: Design, synthesis and biological evaluation.
An Y; Dong Y; Liu M; Han J; Zhao L; Sun B
Eur J Med Chem; 2021 Jan; 210():112991. PubMed ID: 33183866
[TBL] [Abstract][Full Text] [Related]
5. Small-Molecule Inhibitors Targeting Sterol 14α-Demethylase (CYP51): Synthesis, Molecular Modelling and Evaluation Against Candida albicans.
Binjubair FA; Parker JE; Warrilow AG; Puri K; Braidley PJ; Tatar E; Kelly SL; Kelly DE; Simons C
ChemMedChem; 2020 Jul; 15(14):1294-1309. PubMed ID: 32459374
[TBL] [Abstract][Full Text] [Related]
6. Potent arylamide derivatives as dual-target antifungal agents: Design, synthesis, biological evaluation, and molecular docking studies.
Dong Y; Liu X; An Y; Liu M; Han J; Sun B
Bioorg Chem; 2020 Jun; 99():103749. PubMed ID: 32220664
[TBL] [Abstract][Full Text] [Related]
7. Design and optimization of highly-selective fungal CYP51 inhibitors.
Hoekstra WJ; Garvey EP; Moore WR; Rafferty SW; Yates CM; Schotzinger RJ
Bioorg Med Chem Lett; 2014 Aug; 24(15):3455-8. PubMed ID: 24948565
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and antifungal activity of some new imidazole and triazole derivatives.
Rezaei Z; Khabnadideh S; Zomorodian K; Pakshir K; Kashi G; Sanagoei N; Gholami S
Arch Pharm (Weinheim); 2011 Oct; 344(10):658-65. PubMed ID: 21984016
[TBL] [Abstract][Full Text] [Related]
9. Lanosterol 14α-demethylase (CYP51)/histone deacetylase (HDAC) dual inhibitors for treatment of Candida tropicalis and Cryptococcus neoformans infections.
Zhu T; Chen X; Li C; Tu J; Liu N; Xu D; Sheng C
Eur J Med Chem; 2021 Oct; 221():113524. PubMed ID: 33992927
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, and Biological Evaluation of Dual-Target COX-2/CYP51 Inhibitors for the Treatment of Fungal Infectious Diseases.
Liu W; Liu Y; Fan H; Liu M; Han J; An Y; Dong Y; Sun B
J Med Chem; 2022 Sep; 65(18):12219-12239. PubMed ID: 36074863
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and biological evaluation of amide-pyridine derivatives as novel dual-target (SE, CYP51) antifungal inhibitors.
Sun B; Dong Y; Lei K; Wang J; Zhao L; Liu M
Bioorg Med Chem; 2019 Jun; 27(12):2427-2437. PubMed ID: 30765301
[TBL] [Abstract][Full Text] [Related]
12. Lead optimization generates selenium-containing miconazole CYP51 inhibitors with improved pharmacological profile for the treatment of fungal infections.
Xu H; Yan ZZ; Guo MB; An R; Wang X; Zhang R; Mou YH; Hou Z; Guo C
Eur J Med Chem; 2021 Apr; 216():113337. PubMed ID: 33713977
[TBL] [Abstract][Full Text] [Related]
13. Design, Synthesis and Antifungal Activity Evaluation of New Thiazolin-4-ones as Potential Lanosterol 14α-Demethylase Inhibitors.
Stana A; Vodnar DC; Tamaian R; Pîrnău A; Vlase L; Ionuț I; Oniga O; Tiperciuc B
Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106743
[TBL] [Abstract][Full Text] [Related]
14. New azoles with antifungal activity: Design, synthesis, and molecular docking.
Chai X; Zhang J; Cao Y; Zou Y; Wu Q; Zhang D; Jiang Y; Sun Q
Bioorg Med Chem Lett; 2011 Jan; 21(2):686-9. PubMed ID: 21190856
[TBL] [Abstract][Full Text] [Related]
15. Construction and Activity Evaluation of Novel Bifunctional Inhibitors and a COF Carrier Based on a Fungal Infection Microenvironment.
Yu S; He YQ; Liu Y; Ji S; Wang Y; Sun B
J Med Chem; 2024 May; 67(10):8420-8444. PubMed ID: 38718180
[TBL] [Abstract][Full Text] [Related]
16. Synthesis, in vitro evaluation and molecular docking studies of new triazole derivatives as antifungal agents.
Jiang Y; Zhang J; Cao Y; Chai X; Zou Y; Wu Q; Zhang D; Jiang Y; Sun Q
Bioorg Med Chem Lett; 2011 Aug; 21(15):4471-5. PubMed ID: 21737273
[TBL] [Abstract][Full Text] [Related]
17. De novo design of non-coordinating indolones as potential inhibitors for lanosterol 14-α-demethylase (CYP51).
González-Chávez R; Martínez R; Torre-Bouscoulet ME; Gallo M; González-Chávez MM
Chem Pharm Bull (Tokyo); 2014; 62(1):16-24. PubMed ID: 24390489
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and evaluation of benzotriazole derivatives as novel antifungal agents.
Shah JJ; Khedkar V; Coutinho EC; Mohanraj K
Bioorg Med Chem Lett; 2015 Sep; 25(17):3730-7. PubMed ID: 26117563
[TBL] [Abstract][Full Text] [Related]
19. Design, Synthesis, Bioactive Evaluation, and Molecular Dynamics Simulation of Novel 4
Bao A; Jiang W; Xie X; Wang D; Deng Z; Wang J; Li W; Tang X; Yan Y
J Med Chem; 2024 May; 67(10):7954-7972. PubMed ID: 38703119
[TBL] [Abstract][Full Text] [Related]
20. Structural and Functional Elucidation of Yeast Lanosterol 14α-Demethylase in Complex with Agrochemical Antifungals.
Tyndall JD; Sabherwal M; Sagatova AA; Keniya MV; Negroni J; Wilson RK; Woods MA; Tietjen K; Monk BC
PLoS One; 2016; 11(12):e0167485. PubMed ID: 27907120
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
